|Bid||0.9000 x 1000|
|Ask||2.9900 x 1500|
|Day's Range||0.9300 - 1.0700|
|52 Week Range||0.8400 - 3.8400|
|PE Ratio (TTM)||473.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Infinity Pharmaceuticals, Inc. (INFI) reported a wider-than-expected loss in second-quarter 2017 due to the termination of an agreement with AbbVie.
Q2 2017 Infinity Pharmaceuticals Inc Earnings Call
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 34 cents. In the final minutes of trading on Thursday, the company's shares hit $1.36. A year ago, they were trading ...